Skip to main content

AGE (Advanced Glycation End Products) Assay Kit (ab238539) is designed for the rapid detection and quantitation of advanced glycation end product protein adducts.


Images

Competitive ELISA - AGE (Advanced Glycation End) Assay Kit (AB238539), expandable thumbnail
  • Competitive ELISA - AGE (Advanced Glycation End) Assay Kit (AB238539), expandable thumbnail

Publications

Key facts

Detection method

Colorimetric

Sample types

Purified protein, Tissue Lysate, Plasma, Serum, Cell Lysate

Assay type

Competitive

Range

0.36 - 100 µg/mL

Sensitivity

= 0.5 µg/mL

Alternative names

What's included?

96 Test
Components
100X Conjugate Diluent
1 x 300 µL
10X Wash Buffer
1 x 100 mL
AGE Conjugate
1 x 50 µL
AGE-BSA Standard
1 x 125 µL
Anti-AGE Antibody (1000X)
1 x 10 µL
Assay Diluent
1 x 50 mL
Protein Binding Strip Well Plate
1 x 1 Unit
Secondary Antibody, HRP Conjugate (1000X)
1 x 20 µL
Stop Solution
1 x 12 mL
Substrate Solution
1 x 12 mL

Recommended products

AGE (Advanced Glycation End Products) Assay Kit (ab238539) is designed for the rapid detection and quantitation of advanced glycation end product protein adducts.

Key facts

Detection method

Colorimetric

Sample types

Purified protein, Tissue Lysate, Plasma, Serum, Cell Lysate

Assay type

Competitive

Range

0.36 - 100 µg/mL

Assay Platform

Microplate reader

Sensitivity

= 0.5 µg/mL

Storage

Shipped at conditions

Blue Ice

Appropriate short-term storage conditions

Multi

Appropriate long-term storage conditions

Multi

Storage information

Please refer to protocols

Notes

AGE (Advanced Glycation End Products) Assay Kit (ab238539) is designed for the rapid detection and quantitation of advanced glycation end product protein adducts.

Advanced Glycation End Products (AGE) are formed during the Maillard reaction where reducing carbohydrates react with lysine side chains and N-terminal amino groups of various macromolecules, particularly proteins. The advanced glycation end products can adversely affect the fuction of these macromolecules. One of the most prevalent advanced glycation end products, N-epsilon-(Carboxymethyl) Lysine, has been implicated in oxidative stress and vascular damage. The quantity of AGE adduct in protein samples is determined by comparing its OD with that of a known AGE-BSA standard curve.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

Advanced Glycation End-products (AGEs) are highly reactive compounds formed when reducing sugars non-enzymatically bind to proteins lipids or nucleic acids. They are often referred to as AGE products or AGE-BSA when in the form of bovine serum albumin (BSA). The molecular weight of AGE compounds can vary significantly due to the diversity of glycation products. AGEs express in various tissues but accumulate more in aging tissues and in certain pathological states. Detection of AGE products often utilizes AGE ELISA assays or fluorescence-based methods to measure AGE-BSA.

Biological function summary

AGE compounds affect cellular and tissue functions by altering structural proteins and increasing oxidative stress. While not a component of a specific complex AGEs catalyze cross-linking of proteins like collagen impacting tissue elasticity. The binding of AGEs to receptors such as RAGE (Receptor for Advanced Glycation End-products) triggers inflammatory pathways and oxidative stress. This interaction fuels the damaging effects of AGEs in biological systems which are assayed through AGE assays.

Pathways

AGE compounds influence several critical biological pathways particularly the NF-kB and MAPK pathways. These pathways mediate inflammation and cellular stress responses. The interaction with RAGE also affects signaling with related proteins like S100/calgranulins which further activate pro-inflammatory responses. The alteration of these pathways by AGE compounds highlights their significance in cellular dysfunction and age-related conditions.

Associated diseases and disorders

AGE compounds play significant roles in the progression of diabetes and cardiovascular disease. In diabetes AGEs contribute to complications by modifying vascular structure and function where they link with proteins such as HbA1c in glycation. In cardiovascular disease AGE accumulation in vascular tissues enhances vascular stiffness and atherosclerotic lesion formation. The AGE-RAGE interaction perpetuates chronic inflammation further exacerbating these conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Competitive ELISA - AGE (Advanced Glycation End) Assay Kit (ab238539), expandable thumbnail

    Competitive ELISA - AGE (Advanced Glycation End) Assay Kit (ab238539)

    Example AGE-BSA Competitive ELISA Standard Curve.

    Typical AGE Competitive ELISA results.

    This data is for reference only and should not be used to interpret actual results.

  • Competitive ELISA - AGE (Advanced Glycation End) Assay Kit (ab238539), expandable thumbnail

    Competitive ELISA - AGE (Advanced Glycation End) Assay Kit (ab238539)

    Advanced Glycation End Product Formation Pathways.

    CML = N-epsilon-(carboxymethyl)lysine.

    GOLD = glyoxal-derived lysine dimer.

    CEL = N-epsilon-(1-carboxyethyl)lysine.

    MOLD = methylglyoxal-derived lysine dimer.

    DOLD = 3-deoxyglucosone-derived lysine dimer.

    3-DG = 3-deoxyglucosone.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com